Dhadha Ajay Kumar bought RAPH
March 5, 2025 · Form 4 insider transaction
Dhadha Ajay Kumar bought 350,000 shares of Raphael Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
350,000
Price
$0.00
Total value
N/A
InsiderDhadha Ajay Kumar
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 5, 2025
Filing dateMarch 6, 2025
Shares owned after351,667
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
350,000 shares of Common Stock and 250,000 Warrants to purchase shares of Common Stock of the issuer were received as compensation for the reporting person's service as a director and chairman of the Issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 5, 2025. The Warrants are exercisable immediately and will expire on December 31, 2026.